(Q40607428)

22 September 2017

Novel combination of cyclooxygenase-2 and MEK inhibitors in human hepatocellular carcinoma provides a synergistic increase in apoptosis (English)

1 reference

22 September 2017

C Max Schmidt

1

1 reference

22 September 2017

Yufang Wang

series ordinal

2

1 reference

22 September 2017

Chad Wiesenauer

series ordinal

3

1 reference

22 September 2017

language of work or name

1 reference

1 December 2003

1 reference

Journal of Gastrointestinal Surgery

22 September 2017

1 reference

22 September 2017

7

1 reference

22 September 2017

1024-1033

1 reference

22 September 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1016/j.gassur.2003.09.009

22 September 2017

0 references

cites work

Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway

1 reference

12 December 2020

Expression of survivin during liver regeneration

1 reference

12 December 2020

Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites

1 reference

12 December 2020

Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase

1 reference

12 December 2020

NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines

1 reference

12 December 2020

Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells

1 reference

12 December 2020

Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

Expression and role of Bcl-xL in human hepatocellular carcinomas

1 reference

12 December 2020

Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.

1 reference

12 December 2020

10.1016/J.GASSUR.2003.09.009

Identifiers

DOI

1 reference

Dimensions Publication ID

22 September 2017

0 references

1 reference